12:00 AM
 | 
Nov 25, 2013
 |  BC Week In Review  |  Company News  |  Management Tracks

Silence Therapeutics board of directors update

Silence Therapeutics plc (LSE:SLN), London, U.K.
Business: Cancer, Renal, Ophthalmic
Appointed:...

Read the full 35 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >